Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Ad26.COV2.S Emergency use authorization Experimental Vaccine Apr/28/2021 7 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/08/2021 22 0
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021 6 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Apr/01/2021 11 0